Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582296 · ClinicalTrials.gov registry record
Multi-Organ Screening Recommendations in Patients With Lynch Syndrome
A clinical trial of Lynch Syndrome, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 1,530
- Enrollment target
- 8
- Study locations
NCT00582296: Active study of Lynch Syndrome, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00582296 is a study of Lynch Syndrome that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,530 participants, below the 2,244-participant average among 21 other Lynch Syndrome trials with a reported enrollment target (32% lower). The trial reports 8 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582296, a study of Lynch Syndrome, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 1,530 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to examine how people with a family history of colon cancer and other related cancers respond to recommendations for cancer screening after genetic counseling. The purpose of your participation would be to help us learn more about whether people with a personal and/or family history of colorectal cancer and other cancers follow cancer screening recommendations.
Conditions Studied
Interventions
- BEHAVIORAL questionnaires, telephone interview, optional blood drawn
- BEHAVIORAL questionnaires, telephone interview and optional blood drawn
Study Locations (8)
New York
- Memorial Sloan Kettering Cancer Center @ Commack (Consent Only) - Commack
- Memorial Sloan Kettering Westchester (Consent Only) - Harrison
- Memorial Sloan Kettering Cancer Center Hauppauge (Consent Only) - Hauppauge
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (Consent only) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only) - Middletown
- Memorial Sloan Kettering Bergen (Consent Only) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,530 participants |
| Start Date | 2004-12 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582296
The ClinicalTrials.gov registry entry for NCT00582296 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,530 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,244-participant average among 21 other Lynch Syndrome trials with a reported enrollment target (32% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lynch Syndrome appearing as the primary indexed condition, and to 2 interventions - of which questionnaires, telephone interview, optional blood drawn is the first listed.
NCT00582296 reports 8 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT00582296 about?
NCT00582296 is a clinical study titled "Multi-Organ Screening Recommendations in Patients With Lynch Syndrome". The purpose of this study is to examine how people with a family history of colon cancer and other related cancers respond to recommendations for cancer screening after genetic counseling. The purpose of your participation would be to help us learn more about whether people with a personal and/or fa...
What is the current status of trial NCT00582296?
This trial is currently active not recruiting. The enrollment target is 1,530 participants. The study started on 2004-12. Estimated completion is 2026-12.
What conditions does trial NCT00582296 study?
This clinical trial studies the following conditions: Lynch Syndrome.
What interventions are being tested in trial NCT00582296?
The interventions under investigation include: questionnaires, telephone interview, optional blood drawn (BEHAVIORAL), questionnaires, telephone interview and optional blood drawn (BEHAVIORAL).
Who is sponsoring clinical trial NCT00582296?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00582296 being conducted?
This trial has 8 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lynch Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Cancer of the Pancreas Screening-5 CAPS5)Study
RECRUITING · Phase 3
-
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
RECRUITING
-
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
RECRUITING
-
Lynch Syndrome Integrative Epidemiology and Genetics
RECRUITING
-
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
RECRUITING · Phase 2
-
Identifying and Caring for Individuals With Inherited Cancer Syndrome
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.